Arkolith/Insider Trading/ATAI/Form 4

Short Glenn Frank

Chief Scientific OfficerATAI Life Sciences N.V. (ATAI) · full profile →Form 4 · filed Mar 6, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 3, 2025Grant(A)758K—$0758K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-25-007336) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML